Biologics, Biosimilars and Reimbursement

Biologics, Biosimilars and Reimbursement

October 17, 2012 7:30 AM to 9:00 AMRoyal Mayfair Golf and Country Club, Edmonton, Alberta
Format: In Person
Biologics are the fastest growing specialty drug classification on the market. As the population ages and the popularity of biologics increases, employers need to understand the impact these highly successful yet costly drugs can have on benefit plans. Join Suzanne Lepage, a private health plan strategist as she addresses the developments of biologics and how they differ from traditional drug therapies, as well as how the market for biologics and subsequent entry biologics is likely to develop, She will also discuss some of the issues plan sponsors should consider when planning coverage for biologic therapies, including case management, patient support programs, value of the drugs beyond the price tag and evident based plan design and the impact on workplace productivity. Host: Donna McPherson: Great-West Life. Note: Prices below do not include GST
Fees and Registration
Membership TypesRegular Price
Member$38.10 CDN
Associate Member$38.10 CDN
Student Membership$19.05 CDN
Non Member$57.14 CDN
Member PriceNon Member Price
Table of 6$285.72 CDN$285.72 CDN
Event: 21 Registered59 Available
Cancellation Policy
By continuing to use this website, you are agreeing to our use of cookies.